Physician profile
James M Ware
NPI 1275698235
$5,740.03
in general payments reported to CMS, 2019-2025
27 companies · $889 in 2025
The $889 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $823 · 2020: $733 · 2021: $632 · 2022: $803 · 2023: $753 · 2024: $1,107 · 2025: $889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,748.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,240.22 | 2021-2025 | Bodyguardian, Cds - Mct/Cem Monitoring, Synergy |
| Janssen Pharmaceuticals, INC | $1,471.97 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $369.89 | 2019-2025 | |
| Emd Serono, INC. | $307.89 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $244.37 | 2019-2023 | Brilinta |
| E.R. Squibb & Sons, L.L.C. | $203.26 | 2021-2025 | Camzyos, Eliquis |
| Abiomed | $122.34 | 2020-2022 | |
| Allergan, INC. | $113.03 | 2020 | |
| Medtronic, INC. | $85.05 | 2021 | |
| Cvrx, INC. | $75.74 | 2022 | |
| Esperion Therapeutics, INC. | $62.45 | 2020-2024 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $61.07 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $55.68 | 2021-2022 | |
| Abbott Laboratories | $45.80 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $36.18 | 2020-2023 | Opsumit, Uptravi |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $33.45 | 2022-2025 | Repatha |
| Lexicon Pharmaceuticals, INC. | $33.10 | 2023-2024 | Inpefa |
| Lantheus Medical Imaging, INC. | $26.36 | 2023 | Definity |
| Cardiovascular Systems INC. | $25.77 | 2021 | |
| Vital Connect, INC | $22.01 | 2024 | Vitalpatch Rtm |
| Merck Sharp & Dohme LLC | $18.96 | 2022 | |
| Chiesi USA, INC. | $17.41 | 2022 | |
| Shockwave Medical, INC | $17.01 | 2023 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Inspire Medical Systems, INC. | $15.12 | 2025 | Inspire |
| Osprey Medical INC | $14.85 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.05 | 2021 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ware listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.